VRS
INDV icon

Virginia Retirement Systems’s Indivior Pharmaceuticals INDV Stock Holding History

Virginia Retirement Systems’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$761K Buy
21,200
+700
+3% +$21.4K ﹤0.01% 668
2025
Q3 		$494K Buy
+20,500
New +$429K ﹤0.01% 756

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virginia Retirement Systems's INDV Position: Q4 2025 in Review

Virginia Retirement Systems increased its Indivior Pharmaceuticals (INDV) stake by 3.4% in Q4 2025, buying an estimated $21.4K and bringing the position to 21,200 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Virginia Retirement Systems first reported a position in INDV in Q3 2025 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold INDV as of Q4 2025.

  • Virginia Retirement Systems held 21,200 shares of Indivior Pharmaceuticals worth $761K as of Q4 2025.
  • Virginia Retirement Systems bought 700 Indivior Pharmaceuticals shares in Q4 2025, an estimated $21.4K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #668 holding.
  • Virginia Retirement Systems first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.